EpiCast Report: Osteoarthritis – Epidemiology Forecast to 2026

2017-09-04
Price :
Published : Sep-2017
No. of Pages : 50

EpiCast Report: Osteoarthritis – Epidemiology Forecast to 2026

Summary

Osteoarthritis (OA) is a gradually progressive joint disease that is typically seen in middle-aged to elderly people. According to the American College of Rheumatology (ACR), OA is the most common cause of disability in the elderly. The most commonly affected joints are the knee, hip, hand, and spine. It is characterized by breakdown of the cartilage, bony changes of the joints, deterioration of tendons and ligaments, and various degrees of inflammation of the joint lining.

To forecast the total prevalent cases (radiographic), total prevalent cases (symptomatic), and diagnosed prevalent cases (symptomatic) of hand OA, knee OA, and hip OA in the 7MM, GlobalData epidemiologists selected nationally representative, population-based studies that provided these epidemiological data in the 7MM. GlobalData epidemiologists obtained data for the diagnosed prevalent cases (symptomatic) as well as data for the severity segmentation of the diagnosed prevalent cases (symptomatic) from primary market research. In addition, the forecast is supported by robust, country-specific data that was obtained from various authentic sources such as research articles published in peer-reviewed journals.

In the 7MM, GlobalData epidemiologists forecast that the diagnosed prevalent cases (symptomatic) of hand OA will increase from 17,948,101 cases in 2016 to 20,413,591 cases in 2026 at an annual growth rate (AGR) of 1.37%, the diagnosed prevalent cases (symptomatic) of knee OA will increase from 15,235,201 cases in 2016 to 17,641,626 cases in 2026 at an AGR of 1.58%, and the diagnosed prevalent cases (symptomatic) of hip OA will increase from 3,361,141 cases in 2016 to 3,867,480 cases in 2026 at an AGR of 1.51%.

Scope

– The Osteoarthritis (OA) EpiCast Report provides an overview of the risk factors and global trends of hand OA, knee OA, and hip OA in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
– It includes a 10-year epidemiological forecast for the total prevalent cases (radiographic), total prevalent cases (symptomatic), and diagnosed prevalent cases (symptomatic) of hand OA, knee OA, and hip OA segmented by age (beginning at 18 years and older) and sex in these markets. The diagnosed prevalent cases (symptomatic) of hand OA, knee OA, and hip OA are further segmented by severity using Kellgren-Lawrence (KL) grading into mild (KL = 2), and moderate to severe (KL = 3 to 4).
– The OA epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
– The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The OA EpiCast report will allow you to –
– Develop business strategies by understanding the trends shaping and driving the global OA market.
– Quantify patient populations in the global OA market to improve product design, pricing, and launch plans.
– Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for OA therapeutics in each of the markets covered.
– Understand magnitude of OA population by disease severity.

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

Organ Preservation Market by Solution (UW/Custodiol HTK/Perfadex), Technique (Static Cold Storage/Hypothermic Machine Perfusion/ Normothermic Machine Perfusion), Organ Type (Kidneys/Liver/Lungs/Heart), Region – Global Forecast to 2024

“The organ preservation market is projected to grow at a CAGR of 6.5%.” The global organ preservation market is projected to reach USD 284 million by 2024 from USD 207 million in 2019, at a CAGR of 6.5%. The growth of the organ preservation market is mainly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. However, the high cost of organ transplantations and religious concerns in specific geographies are expected to limit market growth to a certain extent. “The University of Wisconsin (UW) holds the market share in the solutions market.” Based on the Solution, the segment is divided into UW, Custodial HTK, Perfadex and......
$5650

Transplant Diagnostics Market by Technology (PCR, NGS, Sanger Sequencing), Product (Instrument, Reagent, Software), Application (HLA, Blood Profile, Pathogen Detection), Type (Heart, Kidney, Liver, Bone Marrow), End User (Hospital) – Global Forecast to 2025

“The global transplant diagnostics market is projected to grow at a CAGR of 7.2% during the forecast period.” The transplant diagnostics market is expected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%. The demand for transplant diagnostic products is expected to grow due to technological advancements in the field of transplant diagnostics and increasing public-private funding for target research activities. The transplant diagnostics market is segmented on product, technology, application, transplant type, end user, and region. “The independent reference laboratories segment accounted for the largest share of the transplant diagnostics market, by end user, in 2019.” Based on end user, the transplant diagnostics market is segmented into i......
$5650

mHealth Solutions Market by Connected Devices (Glucose & Blood Pressure Monitor, Peak Flow Meter, Pulse Oximeter), Apps (Weight Loss, Women Health, Diabetes Management, Mental Health), Services (Remote Monitoring, Consultation) – Global Forecast to 2025

“The mHealth solutions market is expected to grow at a CAGR of 33.3% during the forecast period.” The global mHealth solutions market is projected to reach USD 213.6 billion by 2025 from USD 50.82 billion in 2020, at a high CAGR of 33.3% during the forecast period of 2020 to 2025.The growing adoption of smartphones, increasing penetration of 3G/4G networks, increasing utilization of connected devices and mHealth apps for the management of chronic diseases, rising focus on cost containment in healthcare delivery, rising focus on patient-centric healthcare delivery, and the increasing demand for home healthcare services are some of the key factors driving the greater uptake of mobile technologies among both patients and healthcare professionals. “Based on product and service, the......
$5650

Graft Versus Host Disease: Epidemiology Forecast to 2028

Graft Versus Host Disease: Epidemiology Forecast to 2028 Summary GvHD is a common complication of allogeneic HSCT that occurs when the donated (graft) cells are rejected and attack the host's cells as foreign. GvHD can progress from mild to severe forms as either aGvHD or cGvHD. Both aGvHD and cGvHD commonly affect organs such as the skin, gastrointestinal (GI) tract, liver, oral mucosa, and eyes. The global distribution of GvHD is directly dependent on transplantation-related factors, including the donor type, the age of the donor and the recipient, the sex parity between the recipient and the donor, the pre-transplantation conditioning regimen, and the use of GvHD prophylaxis pre- and/or post-transplantation. GlobalData epidemiologists utilized historical HSCT data available through c......
$3995

Healthcare Fraud Analytics Market by Solution Type (Descriptive, Predictive, Prescriptive), Application (Insurance Claim (Postpayment, Prepayment), Payment Integrity), Delivery (On-premise, Cloud), End User (Insurance, Government) – Global Forecast to 2025

The healthcare fraud analytics market is projected to reach USD 4.6 billion by 2025 from USD 1.2 billion in 2020 at a CAGR of 29.8%. The emergence of social network analytics, the adoption of technologies such as AI and blockchain, and the growing use of healthcare analytics for fraud detection in emerging nations like the APAC provide growth opportunities in this market. However, the time-consuming deployment of these solutions and the need for frequent updates are some challenges faced by end users of this market. The on-demand segment is projected to witness the highest growth during the forecast period On the basis of delivery model, the healthcare fraud analytics market is segmented into on-premise and on-demand models. The on-demand models include the cloud-based and web-based......
$5650

Women’s Health Care Market by Drugs (Prolia, Xgeva, Evista, Mirena, Zometa, Reclast, Nuvaring, Primarin, Actonel), Application (Female Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, PCOS, Menopause) – Global forecast to 2024

“Growing incidence of chronic health conditions among women and the demand in contraceptives to prevent unintended pregnancies are the key factors driving the women’s healthcare market.” The global women’s healthcare market is projected to reach USD 17.8 billion by 2024 from USD 9.6 billion in 2019, at a CAGR of 13.2% during the forecast period. Growth in this market is mainly driven by the growing incidence of chronic health conditions among women, growing demand for contraceptives to prevent unintended pregnancies, growing focus on R&D by key players for the development of advanced products, and the government initiatives to curb population growth. On the other hand, the reluctance to use contraceptives is a major factor limiting the market growth. “Prolia is the larg......
$5650

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – United Arab Emirates

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates Summary GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape -UAE". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the UAE. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape, and healthcare infrastructure of the UAE. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-h......
$1995

Virtual/Augmented Reality in Healthcare – Thematic Research

Virtual/Augmented Reality in Healthcare - Thematic Research Summary Virtual reality (VR) and augmented reality (AR) technologies have been traditionally associated with the entertainment industry, with virtual and immersive environments used for gamers, product designers, and architects. However, increasing healthcare expenditure and the need for cutting-edge technologies to aid the development of novel therapies and diagnostics have fueled the need for this technology in the healthcare industry. As the technology advances and with the availability of cheaper, more user-friendly VR/AR headsets, the barriers to its widespread use in healthcare are beginning to fall. While still in the early stages of adoption, there are myriad possibilities for VR/AR technology in the healthcare sector, i......
$1950

Virtual Care – Thematic Research

Virtual Care - Thematic Research Summary Virtual Care is the intersection between digital technologies and healthcare delivery systems. By integrating new and existing digital technologies such as telehealth, connected medical devices, remote monitoring, mobile device apps, and electronic health records, healthcare systems can expand their services to patient populations whenever and however is most convenient to each individual patient. By allowing patients to interact with their healthcare providers digitally, patients are encouraged to seek out continual care without having to incur the consequences of unnecessary travel, limited access to care services, or lost days of work. Virtual Care offerings allow healthcare systems to greatly expand their patient population reach. This is esp......
$1950

Connected Care – Thematic Research

Connected Care - Thematic Research Summary Connected Care is the continued and emerging integration of smart technologies into the healthcare system. By linking all of the currently available healthcare streams of information to emerging technologies, healthcare systems can vastly increase their efficiency and offerings to patient populations. Traditionally, healthcare systems are compartmentalized units of services that link together to provide patients with solutions to their illnesses and conditions. Digital technologies are enabling healthcare services become fully integrated in order to both optimize care delivery and enable more targeted and seamless healthcare. Paramedics with the ability to identify patients in distress, access their health records electronically, and stabilize ......
$1950
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy